Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
49
天
Novel salicylamido sulfonamides as CD73 immune checkpoint inhibitors: Synthesis and in vitro biological evaluation
作者
Dinesh Krishna Narukulla; Shrilekha Chilvery; Chandraiah Godugu; Avvaru Subha Jahnavi; Amol G. Dikundwar; Venkata Rao Kaki展开收起
作者单位
Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, Hyderabad 500037, Telangana, India.; Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, Hyderabad 500037, Telangana, India.; Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, Hyderabad 500037, Telangana, India.展开收起
106
天
Design and synthesis of dual-target CDK9-EZH2 inhibitors using a pharmacophore fusion strategy
作者
Yixue Han; Ruiqi Wang; Lina Tian; Jian Xiao; Aihuan Wei; Jian Ding; Yi Chen; Youhong Hu; Yanfen Fang; Xin Li展开收起
作者单位
School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China; State Key Laboratory of Chemical Biology, Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China; State Key Laboratory of Drug Research, Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 ZuChongZhi Road, Shanghai, 201203, China; University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing, 110039, China; School of Medicine, Hangzhou City University, Hangzhou 310015, China展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
